Syphilis Antibiotic In Short Supply
Medically reviewed by Drugs.com.
By Physician’s Briefing Staff HealthDay Reporter
FRIDAY, July 7, 2023 -- Infectious disease experts are warning that a shortage of a key antibiotic for treating syphilis could make it hard to fight the spread of the disease.
The United States already has a big problem with syphilis, with cases rising for more than 20 years. Cases increased nearly 75 percent between 2017 and 2021 alone, bringing the number to more than 176,000 in 2021, according to the U.S. Centers for Disease Control and Prevention. Meanwhile, drugmaker Pfizer recently announced the shortage of its Bicillin L-A, also known as penicillin G benzathine, which could continue into next year.
Reasons for scarcity of the long-acting injectable antibiotic include increasing demand because of the rising number of syphilis infections. The medication can also be used in place of amoxicillin to treat infections like strep throat as amoxicillin has also been scarce recently, The New York Times reported.
Among the concerns is congenital syphilis, which has a high fatality rate and can also lead to severe birth defects, The Times reported. Bicillin is the only recommended treatment for infected pregnant women.
Pfizer spokesman Steven Danehy told The Times it will likely take a year to increase production by 50 percent.
The CDC is recommending that doctors give preference for the medication to pregnant patients and infected or exposed infants. Others should be prescribed doxycycline for two to four weeks.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Only Half of Adults Believe They Should Disclose Sexually Transmitted Infection Status
FRIDAY, June 7, 2024 -- Only half of individuals disclose or believe they should disclose having a sexually transmitted infection (STI) prior to sexual intercourse, according to a...
CDC Recommends Doxycycline PEP for Gay Men, Transgender Women
WEDNESDAY, June 5, 2024 -- In clinical guidelines issued by the U.S. Centers for Disease Control and Prevention and published June 4 in the agency's Morbidity and Mortality Weekly...
Doctors Seeing More Atypical, Severe Symptoms in Patients With Syphilis
MONDAY, April 29, 2024 -- Physicians are increasingly seeing cases of syphilis that do not present with typical symptoms, such as rash or skin ulcers, according to a new report...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.